Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Prostatic Neoplasms × Hydroxychloroquine × Clear all

Phase

Phase 2 3 Phase EARLY_PHASE1 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 3 Melanoma 2 Carcinoma, Non-Small-Cell Lung 2 Sarcoma, Clear Cell 1 Rectal Neoplasms 1 Radiation-induced Oral Mucositis 1 Prostatic Neoplasms 1 Prostate Cancer Recurrent 1 Platinum-resistant Epithelial Ovarian Cancer 1 Pancreatic Neoplasms 1 Osteosarcoma 1 Neoplasm Metastasis 1 Lung Neoplasms 1 Gliosarcoma 1 Glioma 1 Glioblastoma 1 Gastrointestinal Neoplasms 1 Colonic Neoplasms 1 Central Nervous System Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma, Hepatocellular 1 Breast Neoplasms, Male 1 Anatomic Stage I Breast Cancer AJCC v8 1 Adenocarcinoma of Lung 1 Adenocarcinoma 1

Interventions

Docetaxel 27 Prednisone 22 enzalutamide 15 pembrolizumab 10 Abiraterone Acetate 9 gallium 68 PSMA-11 8 Radiotherapy 8 Pluvicto 8 Leuprolide 7 Nivolumab 6 Magnetic Resonance Spectroscopy 6 Estramustine 5 Biopsy 5 orteronel 4 olaparib 4 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 4 Specimen Handling 4 Radiotherapy, Intensity-Modulated 4 Granulocyte-Macrophage Colony-Stimulating Factor 4 Cyclophosphamide 4 Carboplatin 4 tremelimumab 3 durvalumab 3 darolutamide 3 cemiplimab 3 cabazitaxel 3 bicalutamide 3 avelumab 3 abiraterone 3 Radiosurgery 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03513211 2023-11-22

HITMAN-PC

St Vincent's Hospital, Sydney

Phase 1/2 Completed

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡